CIK: 0001652044 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 13, 2026
Total Value ($000): $2,579,791 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | METSERA INC | 3,783,528 | $197,992 | 7.7% | $27.22 | — | — | 59267L107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 208,697 | $8,212 | 0.3% | $12.62 | +207.3% | — | 252828108 |
| FHTX | FOGHORN THERAPEUTICS INC | 500,901 | $2,449 | 0.1% | $19.16 | -76.3% | — | 344174107 |
| TSHA | TAYSHA GENE THERAPIES INC | 640,882 | $2,096 | 0.1% | $23.52 | -79.4% | — | 877619106 |
| TCRX | TSCAN THERAPEUTICS INC | 1,077,080 | $1,960 | 0.1% | $9.27 | -84.4% | — | 89854M101 |
| BRNS | BARINTHUS BIOTHERAPEUTICS PL | 1,513,644 | $1,892 | 0.1% | $16.78 | — | — | 91864C107 |
| GUTS | FRACTYL HEALTH INC | 662,584 | $1,054 | 0.0% | $8.42 | -80.9% | — | 35168W103 |
| ALEC | ALECTOR INC | 175,866 | $521 | 0.0% | $18.92 | -90.6% | — | 014442107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 3,345,102 (-19.1%) | $266,437 (+38.0%) | 10.3% | $24.03 | +172.9% | COM | 76155X100 |
| MAZE | MAZE THERAPEUTICS INC | 1,388,583 (-42.4%) | $57,529 (-8.0%) | 2.2% | $12.04 | +185.5% | COM | 578784100 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 744,948 (-49.1%) | $11,681 (+7.7%) | 0.5% | $20.37 | -33.8% | COM | 61225M102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PL | PLANET LABS PBC | 31,942,641 | $629,909 | 24.4% | $9.47 | +51.3% | COM CL A | 72703X106 |
| ASTS | AST SPACEMOBILE INC | 8,943,486 | $649,565 | 25.2% | $25.58 | +179.0% | COM CL A | 00217D100 |
| ARM | ARM HOLDINGS PLC | 1,960,784 | $214,333 | 8.3% | $53.52 | — | SPONSORED ADS | 042068205 |
| PRME | PRIME MEDICINE INC | 16,562,498 | $57,472 | 2.2% | $14.77 | -69.9% | COM | 74168J101 |
| TEM | TEMPUS AI INC | 1,551,102 | $91,593 | 3.6% | $30.66 | +155.1% | CL A | 88023B103 |
| PATH | UIPATH INC | 7,034,337 | $115,293 | 4.5% | $73.33 | -78.8% | CL A | 90364P105 |
| GTLB | GITLAB INC | 2,724,712 | $102,258 | 4.0% | $59.42 | -27.1% | CLASS A COM | 37637K108 |
| FRSH | FRESHWORKS INC | 16,206,643 | $198,531 | 7.7% | $22.50 | -47.5% | CLASS A COM | 358054104 |
| VERA | VERA THERAPEUTICS INC | 241,264 | $12,218 | 0.5% | $15.54 | +128.6% | CL A | 92337R101 |
| RLAY | RELAY THERAPEUTICS INC | 1,568,753 | $13,272 | 0.5% | $37.40 | -80.9% | COM | 75943R102 |
| LYEL | LYELL IMMUNOPHARMA INC | 293,256 | $9,026 | 0.3% | $9.11 | +145.6% | COM NEW | 55083R203 |
| FIG | FIGMA INC | 215,582 | $8,056 | 0.3% | $68.66 | -34.2% | CLASS A COM STK | 316841105 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,823,126 | $35,346 | 1.4% | $11.58 | — | COM NEW | 107924102 |
| OSCR | OSCAR HEALTH INC | 481,988 | $6,926 | 0.3% | $31.30 | -44.7% | CL A | 687793109 |
| SANA | SANA BIOTECHNOLOGY INC | 2,812,500 | $11,447 | 0.4% | $32.56 | -86.2% | COM | 799566104 |
| BEAM | BEAM THERAPEUTICS INC | 321,604 | $8,915 | 0.3% | $21.73 | +17.4% | COM | 07373V105 |
| EXAS | EXACT SCIENCES CORP | 23,205 | $2,357 | 0.1% | $105.58 | -23.9% | COM | 30063P105 |
| DXCM | DEXCOM INC | 1,036,937 | $68,822 | 2.7% | $99.11 | -34.8% | COM | 252131107 |
| TNYA | TENAYA THERAPEUTICS INC | 915,705 | $650 | 0.0% | $21.49 | -93.7% | COM | 87990A106 |
| WGS | GENEDX HOLDINGS CORP | 22,711 | $2,954 | 0.1% | $33.78 | +306.4% | COM | 81663L200 |
| HYPR | HYPERFINE INC | 898,720 | $881 | 0.0% | $9.78 | -87.7% | COM CL A | 44916K106 |
| SPRO | SPERO THERAPEUTICS INC | 889,979 | $2,074 | 0.1% | $12.27 | -81.1% | COM | 84833T103 |
| QNCX | QUINCE THERAPEUTICS INC | 189,122 | $634 | 0.0% | $29.87 | -91.6% | COM | 22053A107 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 698,262 | $1,390 | 0.1% | $26.79 | — | SPON ADS | 05280R100 |
| FULC | FULCRUM THERAPEUTICS INC | 14,262 | $161 | 0.0% | $11.14 | -8.7% | COM | 359616109 |
| RGEN | REPLIGEN CORP | 383 | $63 | 0.0% | $269.41 | -41.9% | COM | 759916109 |